As of Oct 2, 2026 close
- Market cap
- $2.92M
- P/E (TTM)
- —
- Forward P/E
- —
- Dividend yield
- —
- 52-week range
- $0.76$5.80
- Volume (live)
- —
- Avg. volume (3M)
- 33.15K
Revelation Biosciences (REVB) Stock Price & Financial Analysis
Revelation Biosciences Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.76 - $0.81 |
|---|---|
| 52-Week High | $5.80 |
| 52-Week Low | $0.76 |
| Open | $0.81 |
| Volume (last close) | 42.89K |
| Average Volume (3M) | 33.15K |
| Market Cap | 2.92M |
|---|---|
| Shares Outstanding | 3.83M |
| Price to Book (P/B) | 0.29 |
| EV/EBITDA | 0.72 |
| 50-Day MA | $1.00 |
|---|---|
| 200-Day MA | $1.46 |
| 52-Week Change | −50.09% |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Revelation Biosciences at a Glance
Revelation Biosciences (REVB) has a market capitalization of $2.92M. Revenue fell 100.0% year over year.
It holds $11.48M in cash and securities against $739.92K of debt, a net cash position of $10.74M.
Revelation Biosciences does not currently pay a dividend.
The share price is down 49.1% over the past year. At $0.76 it sits near the bottom of its 52-week range of $0.76 to $5.80, below its 200-day moving average of $1.46.
Frequently Asked Questions About Revelation Biosciences
What is the current stock price for REVB?
As of the Oct 2, 2026 close, REVB stock trades at $0.76. The 52-week range is $0.76–$5.80, with a day range of $0.76–$0.81.
What is the P/E ratio for REVB?
The P/E ratio (Price-to-Earnings) for REVB is shown in the Key Statistics section. This valuation metric helps compare Revelation Biosciences, Inc. to industry peers.
Does REVB pay dividends?
Revelation Biosciences does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for REVB?
Analyst ratings and recommendations for REVB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of REVB?
Revelation Biosciences's market capitalization is $2.9M, classifying it as a micro-cap company. Revelation Biosciences operates in the Healthcare sector within the Biotechnology industry.